NCT04151927

Brief Summary

This research study will evaluate changes in resting metabolic rate, appetite, and heart rate variability following overnight exposure (8 h/night) to normobaric hypoxia (NH) or normobaric normoxic (NN). In randomized order, participants will sleep one night in NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) and another night in NN (control) conditions (\~20% oxygen; achieved with nitrogen dilution, equivalent to \~1000 feet elevation).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 5, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

December 11, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2021

Completed
Last Updated

November 29, 2021

Status Verified

November 1, 2021

Enrollment Period

1.8 years

First QC Date

October 26, 2019

Last Update Submit

November 26, 2021

Conditions

Keywords

High altitudeMetabolic adaptationsEnergy balance

Outcome Measures

Primary Outcomes (1)

  • Resting metabolic rate (kcal/d) following exposure to NH or NN conditions

    Resting metabolic rate will be accessed using indirect calorimetry (TrueOne 2400, Parvo Medics, Salt Lake City, UT) following 8 hours of overnight exposure to NH or NN.

    8 hours

Secondary Outcomes (13)

  • Objective appetite following exposure to NH or NN conditions

    8 hours

  • Food preferences following exposure to NH or NN conditions

    8 hours

  • Fasting and postprandial hunger following exposure to NH or NN conditions

    Hunger will be measured pre-meal (0 min), immediately post-meal, and at 15, 30, 45, 60, 90, and 120 min following 8 hours of NH or NN exposure

  • Fasting and postprandial satiety following exposure to NH or NN conditions

    Satiety will be measured pre-meal (0 min), immediately post-meal, and at 15, 30, 45, 60, 90, and 120 min following 8 hours of NH or NN exposure

  • Fasting and postprandial prospective food consumption following exposure to NH or NN conditions

    Prospective food consumption will be measured pre-meal (0 min), immediately post-meal, and at 15, 30, 45, 60, 90, and 120 min following 8 hours of NH or NN exposure

  • +8 more secondary outcomes

Study Arms (2)

Normobaric Hypoxia (NH)

EXPERIMENTAL

Overnight exposure (8 hours) to NH conditions (\~15% oxygen; achieved with nitrogen dilution, equivalent to \~8500 feet elevation) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY).

Device: Normobaric HypoxiaDevice: Normobaric Normoxia

Normobaric Normoxia (NN)

SHAM COMPARATOR

Overnight exposure (8 hours) to NN conditions (\~20% oxygen; achieved with nitrogen dilution, equivalent to \~1000 feet elevation) using a commercially available tent and generator system (Hypoxico, Inc., New York, NY).

Device: Normobaric HypoxiaDevice: Normobaric Normoxia

Interventions

Low oxygen exposure to mimic \~8500 feet elevation.

Normobaric Hypoxia (NH)Normobaric Normoxia (NN)

Normal oxygen exposure to mimic \~1000 feet elevation (sham comparator).

Normobaric Hypoxia (NH)Normobaric Normoxia (NN)

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women aged 20 - 45 years
  • Body mass index between 18.5 - 24.5 kg/m2
  • Born at altitudes less than 2,100 meters (\~7,000 feet)
  • Currently residing in Tallahassee, Florida or the surrounding area
  • Not taking any medication(s) that interfere with metabolism or oxygen delivery/transport for four weeks before and throughout the entire study (e.g., includes sedatives, sleeping aids, tranquilizers, and/or any medication that depresses ventilation, diuretics, alpha, and beta-blockers).
  • Willing to refrain from smoking, vaping, chewing tobacco, and dietary supplement use throughout the entire study
  • Willing to spend two overnight visits on the Florida State University campus.

You may not qualify if:

  • Living in areas that are more than 1,200 m (\~4,000 feet), or have traveled to areas that are more than 1,200 m for five days or more within the last two months
  • Metabolic or cardiovascular abnormalities, gastrointestinal disorders, or any condition that interferes with metabolism or oxygen delivery/transport (e.g., kidney disease, diabetes, cardiovascular disease, etc.)
  • Prior diagnosis of apnea or other sleeping disorders
  • Prior diagnosis of high-altitude pulmonary edema or high-altitude cerebral edema
  • Prior diagnosis of anemia or sickle cell anemia/trait
  • Present condition of alcoholism, anabolic steroid, or other substance abuse issues
  • Women who are pregnant, lactating, planning to become pregnant, or who have had an irregular menstrual cycle in the past six months.
  • Allergies or intolerance to foods included in the standardized or ad libitum meal (e.g., lactose intolerance/milk allergy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University

Tallahassee, Florida, 32306, United States

Location

Related Publications (1)

  • Baker PA, Long AN, Dawson MA, Berryman CE. An overnight, 8-hour low oxygen exposure increases energy expenditure with no effect on energy intake: a randomized, sham-controlled, crossover study. J Nutr. 2026 Jan 5:101319. doi: 10.1016/j.tjnut.2025.101319. Online ahead of print.

MeSH Terms

Conditions

Altitude Sickness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Claire E Berryman, Ph.D.

    Department of Nutrition, Food, and Exercise Science at Florida State University.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 26, 2019

First Posted

November 5, 2019

Study Start

December 11, 2019

Primary Completion

October 2, 2021

Study Completion

October 2, 2021

Last Updated

November 29, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations